Tuesday, October 27, 2020
The CRISPR Journal, by Misha Angrist et al
Read the full article.
Abstract
In September 2020, a detailed report on Heritable Human Genome Editing was published. The report offers a translational pathway for the limited approval of germline editing under certain circumstances and assuming various criteria have been met. In this perspective, three dozen experts from the fields of genome editing, medicine, bioethics, law, and related fields offer their candid reactions to the National Academies/Royal Society report, highlighting areas of support, omissions, disagreements, and priorities moving forward.